Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2010
07/13/2010CA2534006C Use of angiotensin ii receptor antagonists
07/13/2010CA2514022C Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
07/13/2010CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands
07/13/2010CA2500888C Isoquinoline compounds and medicinal use thereof
07/13/2010CA2492827C Oral care composition comprising tropolone compounds and essential oils
07/13/2010CA2481365C Occlusive composition comprising a poly (2-cyanoacrylate) monomer
07/13/2010CA2457451C Naphthyridine derivatives
07/13/2010CA2449163C New use of 2-phenyl-substituted imidazotriazinones
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2445388C Stabilized medicine-releasing compositions
07/13/2010CA2444535C Formoterol/steroid bronchodilating compositions and methods of use thereof
07/13/2010CA2444244C Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
07/13/2010CA2443135C Pharmaceutically active compounds and methods of use
07/13/2010CA2440979C Spirolaximes for use in the treatment of pathologies that respond to ppar-.gamma. receptor activation
07/13/2010CA2432211C Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
07/13/2010CA2432145C Glucopyranosyloxypyrazole derivatives and use thereof in medicines
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2429982C Copper chelators for treating ocular inflammation
07/13/2010CA2427837C Radioactive member for use in brachytherapy and method of making
07/13/2010CA2423488C Thermogelling biodegradable aqueous polymer solution
07/13/2010CA2414239C Analgesic anti-inflammatory patch for topical application
07/13/2010CA2410885C Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2388754C Therapeutic intervention to mimic the effect of caloric restriction
07/13/2010CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same
07/13/2010CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases
07/13/2010CA2356533C Inhibitors of the bitter taste response
07/13/2010CA2349503C Particles coated with granulated crystalline ibuprofen
07/13/2010CA2304970C Method and reagents for n-alkylating ureides
07/13/2010CA2259724C Monoclonal antibody which is specific for activated coagulation factor vii, and its use
07/13/2010CA2245242C Purified sr-p70 protein
07/13/2010CA2183564C Methods for altering fertility
07/13/2010CA2176742C Composition for the in vivo production of therapeutic products
07/08/2010WO2010078556A1 Adjuvant compositions and methods of use
07/08/2010WO2010078543A1 Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer
07/08/2010WO2010078542A1 Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
07/08/2010WO2010078541A1 Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
07/08/2010WO2010078536A1 Inhibition of pcsk9 through rnai
07/08/2010WO2010078449A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
07/08/2010WO2010078440A1 Process and intermediates for the preparation of n-acylated-4-aryl beta-amino acid derivatives
07/08/2010WO2010078430A1 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
07/08/2010WO2010078429A1 Pharmaceutical dosage forms and methods of manufacturing same
07/08/2010WO2010078427A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010WO2010078421A1 Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
07/08/2010WO2010078419A2 Herbal-based nasal solution and method of use thereof
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010078393A1 Kinase inhibitors
07/08/2010WO2010078373A1 Substituted diketopiperazine analogs for use as drug delivery agents
07/08/2010WO2010078348A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
07/08/2010WO2010078322A1 Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
07/08/2010WO2010078319A1 Lipoic acid containing compositions for use in the treatment and prevention of ki dney- related disorders in companion animals
07/08/2010WO2010078307A1 Spiro-oxindole-derivatives as sodium channel blockers
07/08/2010WO2010078300A1 Dual functioning ionic liquids and salts thereof
07/08/2010WO2010078294A1 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
07/08/2010WO2010078285A2 Pharmaceutical compositions and methods of treating neurological insults
07/08/2010WO2010078258A1 Compounds comprising two or more biologically functional ions and method of treating parkinson's disease
07/08/2010WO2010078250A1 Synthesis of (2-amino)-tetrahydrocarbazole-propanoic acid
07/08/2010WO2010078247A1 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
07/08/2010WO2010078229A1 Anti-viral compounds, treatment, and assay
07/08/2010WO2010078181A1 Cosmetic use of 1-aroyl-n-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
07/08/2010WO2010078103A1 Modulators of cystic fibrosis transmembrane conductance regulator
07/08/2010WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010WO2010077976A2 Prokineticin receptor antagonists and uses thereof
07/08/2010WO2010077971A2 Acne treatment powder foundation
07/08/2010WO2010077947A1 Phthalazinone and related analogs as sirtuin modulators
07/08/2010WO2010077935A1 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
07/08/2010WO2010077933A1 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
07/08/2010WO2010077928A2 Flavononol renin inhibitor compounds and methods of use thereof
07/08/2010WO2010077927A1 Compositions comprising melperone and controlled-release dosage forms
07/08/2010WO2010077916A1 Compositions comprising melperone
07/08/2010WO2010077911A1 Enema formulations
07/08/2010WO2010077908A1 Oral formulations
07/08/2010WO2010077903A1 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
07/08/2010WO2010077894A2 Methods of inhibiting quiescent tumor proliferation
07/08/2010WO2010077883A2 Antagonists of lysophosphatidic acid receptors
07/08/2010WO2010077882A2 Antagonists of lysophosphatidic acid receptors
07/08/2010WO2010077861A1 Inhibitors of diacylglycerol aclytransferase
07/08/2010WO2010077852A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
07/08/2010WO2010077839A1 Substituted oxindol cb2 agonists for pain treatment
07/08/2010WO2010077758A1 Compounds useful for inhibiting chk1
07/08/2010WO2010077741A1 Diagnosis and therapy of organ dysfunction using sphinganine-1-phosphate
07/08/2010WO2010077740A2 Novel antiviral compounds, compositions, and methods of use
07/08/2010WO2010077734A2 Novel antiviral compounds, compositions, and methods of use
07/08/2010WO2010077723A1 Method for treating nocturia
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010077681A1 Topically active steroids for use in radiation and chemotherapeutics injury
07/08/2010WO2010077671A2 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
07/08/2010WO2010077669A2 Palonosetron formulation
07/08/2010WO2010077663A2 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof
07/08/2010WO2010077655A1 Frequency modulated drug delivery (fmdd)
07/08/2010WO2010077642A1 Method of modulating hsf-1
07/08/2010WO2010077624A1 Biaryl carboxamides
07/08/2010WO2010077613A1 Modulators of toll-like receptors
07/08/2010WO2010077603A1 Inhibition and dispersion of biofilms in plants with imidazole-triazole derivatives
07/08/2010WO2010077589A2 Stat3 inhibitors and therapeutic methods using the same
07/08/2010WO2010077586A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
07/08/2010WO2010077582A1 Triazole derivatives for treatment of alzheimer's disease
07/08/2010WO2010077578A1 Bis-modified bicyclic nucleic acid analogs
1 ... 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 ... 7860